Release according to article 40 para. 1 WpHG
Leverkusen, Germany (pta024/08.11.2022/15:30) - Release of Voting Rights Announcement
Voting Rights Announcement
1. Details of issuer:
| Name: | Biofrontera AG |
| Legal Entity Identifier (LEI): | 391200D6GFSVFGFQTL13 |
| Street: | Hemmelrather Weg 201 |
| Postal code: | 51377 |
| City: | Leverkusen, Germany |
2. Reason for notification:
Acquisition / disposal of shares with voting rights
3. Details of person subject to the notification obligation
Legal entity: Quirin Privatbank AG
City of registered office, country: Berlin, Germany
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
5. Date on which threshold was crossed or reached
02.11.2022
6. Total positions
| % of voting rights attached to shares (total of 7.a.) | % of voting rights through instruments (total of 7.b.1 + 7.b.2) | Total of both in % (7.a. + 7.b.) | Total number of voting rights pursuant to Sec. 41 WpHG | |
| New | 5.03 | 2.22 | 5.03 | 56,717,385 |
| Previous notification (if applicable) | 4.73 | 2.22 | 4.73 |
7. Details on total positions
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
| ISIN | Absolute direct (Sec. 33 WpHG) | Absolute indirect (Sec. 34 WpHG) | In % direct (Sec. 33 WpHG) | In % indirect (Sec. 34 WpHG) |
| DE0006046113 | 2,854,410 | 0 | 5.03 | 0.00 |
| Total: | 2,854,410 | 5.03 |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
| Type of instrument | Maturity / Expiration | Exercise or conversion period | Voting Rights Absolute | Voting Rights in % |
| Option agreement (see note 10) | 30.11.2022 | 30.11.2022 | 1,262,092 | 2.22 |
| Total: | 1,262,092 | 2.22 |
b.2 Instruments according to Sec. 38 (1) no. 2 WpHG
| Type of instrument | Maturity / Expiration | Exercise or conversion period | Cash or physical transaction | Voting Rights Absolute | Voting Rights in % | |
| n/a | 0 | 0.00 | ||||
| Total: | 0 | 0.00 |
8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
| Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting: N/A
10. Other useful information
An aggregation of the financial instrument according to § 38 para. 1 no. 1 WpHG with voting rights according to § 33 WpHG is exceptionally not carried out in the present report, as the financial instrument partly relates to voting rights which are already included in the position according to § 33 WpHG (namely 2.22%). The 5.03% voting rights are composed of 2.81% owned shares and 2.22% shares assigned by security.
Date
07.11.2022
(end)
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com
ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: US OTC